Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1995-05-02
1997-03-25
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514182, 514547, A61K 31685, A61K 3156, A61K 31225
Patent
active
056145071
ABSTRACT:
Protein and peptide free compositions are described, which are useful in treating endotoxemia. The compositions contain a phospholipid and a neutral lipid, preferably phosphatidylcholine and triglyceride.
REFERENCES:
patent: 4703062 (1987-10-01), Blackburn et al.
patent: 5000958 (1991-03-01), Fountain et al.
CA 114:2291, Morton et al., 1990.
Cu eet al., "Recognized High Density Lipoprotein Inhibits Physiologic and Tumor Necrosis Factor .alpha. Responses to Lipopolysaccharide in Rabbits", Arch. Surg. 129: 197 (Fed. 1994).
Glueck et al., "severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women", J. Lab. Clin. Med. 123: 59-.GAMMA.(1994).
Read et al., "Chylomicrons Enhancer Endotoxin Excretion in Bile", Infect & Immun. 61(8): 3496-3502 (Aug. 1993).
Harris et al., "Chylmicrons Alter The Fate of Endotoxin Decreasing Tumor Necrosis Factor Release and Preventing Death", J. Clin. Invest. 91: 1028-1034 (Mar. 1993).
Eichbaum et al., "Chylomicrons Can Inhibit Endotoxin Activity In Vitro", J. Surg. Res. 51(5): 413-416 (Nov. 1991).
Feingold et al., "Endotoxin Rapidly Induces Changes In Lipid Metabolism that Produce Hypertriglyceridemia: Low Doses Stimulated Hepatic Triglyceride Production While High doses Inhibit Clearance:," J. Lipid Res. 33: 1765-1776 (1992).
Harris et al., "Detection of Endotoxin In Triglyceride Rich Liproproteins In Vitro", J. Lab. Clin. Med. 118: 186-193 (1991).
Harris et al., "Human Very Low Density Lipoproteins and Chylomicrons Can Protect Against Endotoxin Induced Death In Mice", J. Clin. Invest. 86: 696-702 (Sep. 1990).
Farmer et al., "Hyper lipoproteinemia and Pancreatitis", Am. J. Med. 54: 161-165 (1973).
Maranhao et al., "Metabolic Behavior in Rats of a Nonprotein Microemulsion Resembling Low Density Lipoprotein", Lipids 28(8): 691-695 (1993).
Miller and Small, "Structure of Triglyceride-Rich Lipoproteins: Analysis of Care & Surface Phases" in gotto, Jr., ed. Plasma Lipoproteins (Elsevier Science Publishers 1987), pp. 1-69.
Gordon Bruce R.
Levine Daniel M.
Parker Thomas S.
Rubin Albert L.
Saal Stuart D.
Jordan Kimberly
The Rogosin Institute
LandOfFree
Protein and peptide free, neutral lipid and phospholipid contain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein and peptide free, neutral lipid and phospholipid contain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein and peptide free, neutral lipid and phospholipid contain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203489